Heron Therapeutics | HRTX - 株式

株価
0.85
毎日の変更
0.03 4.10%
毎月
-12.06%
毎年
-55.34%
Q2 予測
0.83




株式 変化する 日付
ALKERMES USD 196.62M 5.63M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
ANI Pharmaceuticals USD 143.07M 3.41M 2025-12
Anika Therapeutics USD 18.79M 2.5M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Eisai JPY 236.46B 9.14B 2025-09
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.07M 11.1M 2025-12
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
Merck USD 6.44B 157M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Omeros USD 712K 266K 2021-09
Pacira USD 152.86M 4.82M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Surmodics USD 15.17M 230K 2024-09
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Veracyte USD 20.55M 219K 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12